Associated Papers
Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula.
Carano F et al.
Annals of Human Biology, 2018
Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.
Čolić A et al.
Drug Metabolism Reviews, 2015
Allele and genotype frequencies of CYP2B6 in a Turkish population.
Yuce-Artun N et al.
Molecular Biology Reports, 2014
Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?
Singh V et al.
Cancer Investigation, 2008
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.
Rotger M et al.
Clinical Pharmacology and Therapeutics, 2007
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
Crettol S et al.
Clinical Pharmacology and Therapeutics, 2005
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.
Lang T et al.
Pharmacogenetics, 2001
Select a paper to view details